Patents by Inventor Eriko JIMBO

Eriko JIMBO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for improving mitochondrial dysfunction, preventative or therapeutic agent for diseases or symptoms caused by mitochondrial dysfunction, and applications therefor
    Patent number: 11369615
    Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: June 28, 2022
    Assignees: JICHI MEDICAL UNIVERSITY, TOHOKU UNIVERSITY
    Inventors: Hitoshi Osaka, Takanori Yamagata, Eriko Jimbo, Akihiko Miyauchi, Takaaki Abe
  • AGENT FOR IMPROVING MITOCHONDRIAL DYSFUNCTION, PREVENTATIVE OR THERAPEUTIC AGENT FOR DISEASES OR SYMPTOMS CAUSED BY MITOCHONDRIAL DYSFUNCTION, AND APPLICATIONS THEREFOR
    Publication number: 20200330475
    Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.
    Type: Application
    Filed: November 7, 2018
    Publication date: October 22, 2020
    Applicants: JICHI MEDICAL UNIVERSITY, TOHOKU UNIVERSITY
    Inventors: Hitoshi OSAKA, Takanori YAMAGATA, Eriko JIMBO, Akihiko MIYAUCHI, Takaaki ABE